Susan Vadaparampil, Ph.D., MPH


Susan Vadaparampil, Ph.D., MPHDr. Vadaparampil’s research uses a combination of behavioral science, epidemiology, health services, and clinical perspectives to understand and improve dissemination and uptake of new cancer prevention and control innovations including genetic testing for hereditary cancer susceptibility and HPV vaccination. Dr. Vadaparampil has successfully obtained grants from both the NIH and the ACS to support her research program. She currently leads an NCI-funded study to examine physician, systems, and policy level factors influencing recommendation of HPV vaccination among a national sample of physicians from three primary care specialties. She recently completed a longitudinal study funded by the ACS to examine the psychosocial impact of genetic testing on recently diagnosed breast cancer patients. Due to a long-standing interest in health disparities, Dr. Vadaparampil also leads and collaborates on several projects to reduce disparities across the cancer prevention and control continuum.

Educational and Institutional Background

University of Florida, Gainesville, FLBSHealth Science Education
University of Florida, Gainesville, FLMHSEPublic Health Education
Indiana University, Bloomington, INPhDHealth Behavior
Johns Hopkins University, Baltimore, MDMPHEpidemiology
National Cancer Institute, Bethesda, MDPostdocCancer Prevention

Current Position

  • Senior Member, Department of Health Outcomes and Behavior, Division of Population Science, Moffitt Cancer Center, Tampa, FL
  • Professor, Morsani College of Medicine, University of South Florida, Tampa, FL

Research Background

Over the past 14 years, Dr. Vadaparampil has developed a research program applying behavioral science, epidemiology, health services, and clinical perspectives to improve utilization of cancer prevention and control innovations across the cancer continuum. Her work has been influenced by transdisciplinary collaboration, focused on health disparities, and contributed to both the scientific literature and clinical practice. Over the past several years, she has applied these perspectives to several at risk groups including individuals at increased risk for inherited cancer susceptibility, loss of fertility due to cancer related treatment, and most recently, individuals at risk for cancers related to HPV infection. Her research has been funded by the National Institutes of Health, the American Cancer Society, and the Florida Breast Cancer Foundation.